NCT00372996 2015-10-28
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
Pfizer
Phase 2 Terminated
Clinical Trials
4 trialsNCT00678626 2015-05-04
Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer
Pfizer
Phase 2 Withdrawn
NCT00635245 2015-03-11
CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
Pfizer
Phase 1 Withdrawn
NCT00976508 2013-12-13
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Pfizer
Phase 1 Terminated